Lipid composition heatmap for Study ST003432

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:100 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:50 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:100 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:50 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:QC | Drug Treatment:NA
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines11
Saturated FA6
Unsaturated FA1
  logo